Omicron will be home for Christmas

Omicron Will Be Home for Christmas | Quick Take | GZERO Media

Ian Bremmer's Quick Take:

Happy Monday, and yeah, I think I'm still talking to you about the pandemic. I was hoping I would be talking a lot less about the pandemic these days, but we are in the midst of very significant learning on the omicron variant, and I thought I would share what we know and what we really don't know, because the headlines obscure that.

What we know: Big news is that the vaccines don't work very well at all to prevent spread. And that's even true for the mRNA vaccines, the best vaccines, Pfizer and Moderna, that if you've taken two shots, which means that you're considered fully vaccinated and you've got your app, or you've got your vaccine passport, you really aren't protected from getting infected from omicron. Pfizer showing after two vaccine jabs something like 23% effectiveness, which is not effective at all. And the non-mRNA vaccines look like they're even worse, which means that a very, very transmissible strain is not being prevented by the vaccines. That's the bad news, and it's bad news.

Having said that, we know that they work really well to prevent hospitalization and death. And that's not just true for the mRNA vaccines. It's true for other vaccines too. And by the away, it's true even before you get a booster shot. In other words, if you've just gotten two shots from Pfizer, two shots from Moderna, you're really not going to get hospitalized or die from COVID. It's very, very unlikely indeed, but you are quite likely to be able to contract it and spread it, and that's a problem.

Now, we've seen a lot of headlines that say that Omicron is milder as a variant. And the reality is, we don't know that. What we know is that a lot more people are vaccinated, and we also know that the vaccinated people are particularly among those that are most vulnerable. The oldest, the people that have preexisting conditions. That is a population that is very significantly vaccinated, in some countries close to 100%, which means that the outcomes are milder than they would have been from delta, simply because omicron is hitting populations that are more protected against hospitalization and death. And that the people that aren't vaccinated are primarily people that aren't likely to get sick from COVID. Younger, healthier populations. But we don't yet have any conclusions around to what extent you are equally or more or less likely to get seriously sick if you are unvaccinated, even if you're unvaccinated and you already got COVID, than from delta. And that uncertainty is something we probably won't have real data on for at least another week or two.

And I will tell you that the epidemiologists that I've been talking to tell me that if they were to guess, they'd guess that so far, educated guess, that it's probably about the same or maybe a little milder, but not much, than delta, and that most of the change is from the change in population, as opposed to the impact of the disease.

Okay. We also know that omicron is spreading really, really fast. That it's going to be dominant in the United Kingdom and very shortly as a variant. It's already in 30 states that we know of in the US. That means it's really in every US state, and it will be the dominant spread in the United States within a few weeks. So yes, omicron will be home for Christmas. And also some good news is that vaccinations are getting pushed up. We're seeing people more quickly get vaccinated, get their boosters as a consequence of the news around omicron.

Having said all of that, the staggering level of spread even among vaccinated populations mean that hospitals could easily get overwhelmed again as a consequence of this. In the next week in the United Kingdom, that's absolutely possible. In Denmark, that's absolutely possible. And in the United States over the coming month, that's absolutely possible as well. So we are not out of the woods, and that means in terms of travel, in terms of vaccine passports, you're going to see a lot of changes.

Increasingly, if you've got two vaccines, that's not going to be seen as enough to travel internationally, which is annoying to a lot of people, because you kind of assumed that it would even a week or two ago. Now, no, not so much. And what if you've been boosted? Well, you're probably going to need another booster in six months' time. Again, in all of the apps and the vaccine passports and the papers that are allowing you to go to restaurants, and shows, and travel, in those places where those regulations exist are likely to get updated to require a booster shot, and then eventually another booster shot, too.

Madness. When does it all end? Well, it is a problem because the nature of the vaccines and the relationship with the disease make this much harder to politically respond to. In other words, the argument for getting your booster shot is not about whether or not you're going to get sick. The argument about getting the booster shot and another booster shot is about protecting people that are unvaccinated, protecting those that are immunocompromised, even if they have been vaccinated, and that's a harder argument to make. It's a harder argument for politicians to be effective at. It's a harder argument to push mandates upon a population.

And having said that, you look at the last few months, and Kaiser Family Foundation just put out a study in the United States where we're still seeing 1,000 deaths on an average day from COVID. 163,000 people did not have to die from COVID if we had gotten full vaccination rates. In other words, the science was there, the vaccines were there, and just the effectiveness of those vaccines on populations that are not immunocompromised, 163,000 people would be alive today that are not from COVID because we couldn't get our act together in getting vaccines rolled out, getting people to be willing to take them.

And that is the problem going forward. I'm not going to die from COVID. If you've been vaccinated, you're not going to die from COVID, but a lot of people will. And they will from this omicron variant, because we are unable to ramp out boosters fast enough, and second boosters fast enough, which a lot of people are sick of, a lot of people aren't going to feel comfortable with. We don't have the regulatory capacity to get it done, and that means the non-vaccinated population is going to be incredibly vulnerable and exposed. And it also means that economic impact of all of that will continue to grow, and that's around the world. That's not just the United States, that's everywhere, and that's particularly older and vulnerable populations.

So that's what we're looking at. Merry Christmas to everybody. I'm sorry. I wish I had better news on that front. I'm still hoping that over the next week or two, we get more information that will allow us to say that omicron is actually somewhat milder in form than delta is, but right now we don't have that information. The information we have is not so happy. So that's it, and I hope everyone is doing okay, and I will talk to you all real soon.

More from GZERO Media

Proud Source became a Walmart supplier in 2021. Today, its team has grown by 50%, and it's the largest employer in Mackay, ID. Walmart supports small businesses across the country, and nearly two-thirds of Walmart's product spend is on products made, grown, or assembled in America. It’s all a part of Walmart’s $350 billion investment in US manufacturing, which helps small businesses grow and supports US jobs. Learn more about Walmart’s commitment to US manufacturing.

Quantum technology offers the next frontier of innovation. As the global race for quantum technology intensifies, Microsoft Vice Chair and President Brad Smith highlights the need for the United States to harness its heritage of scientific innovation and outlines three strategic actions to ensure American quantum leadership. These actions include increasing government-funded quantum research, developing a skilled quantum workforce, and securing the quantum supply chain. Learn more here.

US Vice President JD Vance meets India’s Prime Minister Narendra Modi in New Delhi, India, on April 21, 2025.
India’s Press Information Bureau/Handout via EYEPRESS

If there’s a winner from President Donald Trump’s trade wars, India is a good candidate. Its longtime rivalry with China gives Prime Minister Narendra Modi ample motive to build new bridges with the United States.

President Donald Trump gives a thumbs up as he returns to the White House on Feb. 22, 2025.

REUTERS/Craig Hudson

This week marks 100 days of the second Trump administration. Against a political timekeeping system of late that has been measured by the shelf life of lettuce (British Prime Minister Liz Truss’ seven weeks in office) and “Scaramuccis” (Anthony Scaramucci’s 10 days as White House communications director during Trump 1.0), the first 100 days of this administration feels like an anomaly.

Canadian Prime Minister Mark Carney speaks in the small hours of April 29, 2025, in Ottawa after his Liberal Party won the general election the previous day.
Kyodo via Reuters

The Liberals have won the battle to lead Canada, securing 168 of 343 parliamentary seats.

Qatar's Emir Sheikh Tamim Bin Hamad Al Thani receives Syrian President Ahmed al-Sharaa, in Doha, Qatar, earlier this month. Qatar and Saudi Arabia have now jointly agreed to pay off Syria's World Bank debt.
Amiri Diwan/Handout via REUTERS

The country's interim president Ahmed al-Sharaa faces a tricky tradeoff when it comes to securing the country.